Cite
Massimo A, Teti E, Antinori A, et al. Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program. Clin Infect Dis. 2016;64(5):680-683doi: 10.1093/cid/ciw846.
Massimo, A., Teti, E., Antinori, A., Milazzoi, L., Sollima, S., Rizzardini, G., Di Biagio, A., Saracino, A., Bruno, R., Borghi, V., De Luca, A., Cattelan, A., Hasson, H., Taliani, G., Monforte, A. D., Mastroianni, C. M., Di Perri, G., Bigoni, S., Puoti, M., Spinetti, A., Gori, A., Boffa, N., Bruno, C., Giacometti, A., Parruti, G., Vullo, V., Chirianni, A., Pennica, A., Pasquazzi, C., Segala, D., Sarmati, L. (2017). Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 64(5), 680-683. https://doi.org/10.1093/cid/ciw846
Massimo, Andreoni, et al. "Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program." Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 64,5 (2017): 680-683. doi: https://doi.org/10.1093/cid/ciw846
Massimo A, Teti E, Antinori A, Milazzoi L, Sollima S, Rizzardini G, Di Biagio A, Saracino A, Bruno R, Borghi V, De Luca A, Cattelan A, Hasson H, Taliani G, Monforte AD, Mastroianni CM, Di Perri G, Bigoni S, Puoti M, Spinetti A, Gori A, Boffa N, Bruno C, Giacometti A, Parruti G, Vullo V, Chirianni A, Pennica A, Pasquazzi C, Segala D, Sarmati L. Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Combination Treatment in Patients with HIV/HCV Co-Infection: Results of an Italian Compassionate Use Program. Clin Infect Dis. 2017 Mar 01;64(5):680-683. doi: 10.1093/cid/ciw846. Epub 2016 Dec 22. PMID: 28011605.
Copy
Download .nbib